OP36 Investigating the role of bioactives produced by gut bacteria to modulate immune response in inflammatory bowel disease
ECCO'20 Vienna
2020
OP37 Fibrogenesis in chronic DSS colitis is driven by an innate lymphoid cell-independent innate immune response
ECCO'20 Vienna
2020
OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial
ECCO'20 Vienna
2020
OP39 Treatment of ulcerative colitis With AMT-101, a novel oral interleukin-10 immunomodulatory fusion biologic that traffics across the intestinal epithelium
ECCO'20 Vienna
2020
OP40 A core transferable microbiota in responders to faecal microbiota transplant for ulcerative colitis shape mucosal T-cell immunity
ECCO'20 Vienna
2020
P001 The novel DYRK1a inhibitor VRN024219 alleviates disease severity on the IBD mouse models by modulating T-cell differentiation
ECCO'20 Vienna
2020
P002 Specific genome editing to model hypermethylation of the SP140 gene that associates to Crohn’s disease
ECCO'20 Vienna
2020
P003 Metabolomics for improved patient stratification in inflammatory bowel disease: Characterisation of the ulcerative colitis metabolome
ECCO'20 Vienna
2020
P004 PN-943, an oral α4β7 integrin antagonist, inhibits MAdCAM1-mediated proliferation and cytokine release from CD4+ T cells independent of trafficking
ECCO'20 Vienna
2020
P005 Regulators of the guanylate cyclase pathway are potential novel markers of mucosal healing in IBD
ECCO'20 Vienna
2020
P006 3D Multicellular intestine-on-a-chip model for disease modelling and drug discovery
ECCO'20 Vienna
2020
P007 GC1qR driven oxidative phosphorylation is essential for intestinal goblet cell differentiation
ECCO'20 Vienna
2020
P009 The innate cytokines IL-1α and TNF-α induce the expression of Oncostatin M and its type II receptor in human colonic subepithelial myofibroblasts
ECCO'20 Vienna
2020
P010 Measurement of colonic mucosal content of biologics with the use of magnetic resonance imaging (MRI): A pilot study in patients with ulcerative colitis
ECCO'20 Vienna
2020
P011 Dysbiosis and Goblet cells depletion triggers early intestinal barrier dysfunction that precedes gut inflammation in IL-10 deficient mice (IL-10−/−)
ECCO'20 Vienna
2020